
Yahoo · 29 de jul de 2026
BlackRock disclosed ownership of 26.5 million HIMS shares, representing a stake of about 12%.
Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
No hay suficientes datos históricos para mostrar el gráfico de HIMS.
Precio
$ 11.700
Var. %
0%
Precio HIMS
US$ 28,77
Teórico (precio / ratio)
HIMS ÷ 4
US$ 7,19
Cotización
US$ 7,40
vs teórico
+2,88%
Cotización MEP implícita
$ 1.581,08
Cotización
US$ 8,17
vs teórico
+13,59%
Cotización Cable implícita
$ 1.432,07
Sí, existe el CEDEAR de HIMS (Hims & Hers Health, Inc.) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es HIMS.
El ticker del CEDEAR de Hims & Hers Health, Inc. en Argentina es HIMS. La acción subyacente cotiza en NYSE con el símbolo HIMS.
El CEDEAR HIMS tiene un ratio de 4:1. Eso significa que 4 CEDEARs equivalen a 1 acción de HIMS.
El CEDEAR HIMS cotiza hoy a $ 11.700 en pesos argentinos, con una variación diaria de 0%.
La acción subyacente HIMS (Hims & Hers Health, Inc.) cotiza a US$ 28,77 en su mercado de origen (NYSE).
El precio teórico del CEDEAR HIMS se calcula dividiendo el precio de HIMS por el ratio (4). Hoy resulta en US$ 7,19.
En BYMA podés operar HIMS en pesos, HIMSD en dólar MEP y HIMSC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR HIMS en pesos argentinos, con datos de data912.

Yahoo · 29 de jul de 2026
BlackRock disclosed ownership of 26.5 million HIMS shares, representing a stake of about 12%.

Yahoo · 28 de jul de 2026
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $29.32, indicating a -3.04% shift from the previous trading day.

SeekingAlpha · 28 de jul de 2026
Hims & Hers is a subscriber-based online healthcare provider that operates outside of the traditional paradigm. Learn why HIMS stock is a buy.

Yahoo · 27 de jul de 2026
An FDA advisory panel backed six of seven peptides for possible inclusion on the 503A compounding list, with Emideltide the only rejection.

Yahoo · 25 de jul de 2026
Joe Spector helped build a multibillion-dollar telehealth company. Now he’s on to own remote vet services.

Yahoo · 25 de jul de 2026
Hims & Hers Health Inc. is in the spotlight Friday after an FDA advisory panel voted Thursday to recommend four key peptides be added to a federal list that wou…

Yahoo · 24 de jul de 2026
A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The trend was highlighted in HCA Healthcare's rec…

Yahoo · 24 de jul de 2026
Hims & Hers shares crash as FDA panel votes against emideltide’s addition to the 503A Bulks List. Here’s what the news means for HIMS stock.
Noticias vía Finnhub